Camlin Fine Sciences Limited

Total Valuation

Camlin Fine Sciences Limited carries a market capitalization of 25.50B, placing it among publicly traded companies globally. Its enterprise value stands at 23.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Camlin Fine Sciences Limited currently has 192.09M shares outstanding.

Valuation Ratios

Camlin Fine Sciences Limited trades at a trailing price-to-earnings ratio of 66.38. The price-to-sales ratio is 1.04, and the price-to-book ratio stands at 95.46.

Enterprise Valuation

On an enterprise value basis, Camlin Fine Sciences Limited trades at an EV/EBITDA multiple of 15.49 and an EV/FCF ratio of 30.47. The EV/Sales ratio of 1.30 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.49 provides insight into valuation relative to core operating earnings.

Financial Position

Camlin Fine Sciences Limited maintains a current ratio of 1.27, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 71.95, indicating elevated leverage, while an interest coverage ratio of 1.95 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Camlin Fine Sciences Limited's stock has declined approximately -55.79614% over the past 52 weeks. The 50-day moving average sits at 129.15, while the 200-day moving average is 149.48.

Income Statement

Over the trailing twelve months, Camlin Fine Sciences Limited generated 17.65B in revenue and converted that into 276.27M in net income, yielding earnings per share of -1.96. EBITDA reached 1.49B, while operating income came in at 1.49B.

Balance Sheet

Camlin Fine Sciences Limited holds 2.11B in cash and equivalents against 7.20B in total debt, resulting in a net debt position of 5.60B. Total book value stands at 192.09M, with working capital of 2.62B providing operational flexibility.

Margins

Camlin Fine Sciences Limited operates with a gross margin of 46.16, reflecting its pricing power and cost economics. The operating margin of 8.42 and net profit margin of 1.56 provide insight into operational efficiency.

Stock Splits

Camlin Fine Sciences Limited's most recent stock split took place on September 4, 2014 with a 1:2 split ratio.

Scores

Camlin Fine Sciences Limited posts an Altman Z-Score of 2.08, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.